sub 3 sub 3 hbr 34 5413 34 ch sub 3 h h ch sub 3 hcl 34 2414 34 h h ch sub 3 ph hbr 34 4915 34 h h ph ch sub 3 hbr 34 5316 34 ch sub 3 h h p clph hbr 34 5817 34 ch sub 3 h h p no sub 2 ph hbr 34 4818 34 ch sub 3 h h 3 4 diclph hbr 34 4219 34 h h ch sub 2 cooh ph hbr 100ip 2420 34 34 h ph 3 4 dicl 20 36 benzyl cl21 34 34 h p brph none 40 4922 34 34 h 34 propargyl br 100 3623 34 34 h 34 u03b1 methyl 40 27 propargyl cl24 34 34 h 34 4 chloro 2 60 20 buteneyl cl25 34 34 h ch sub 3 none 150 4426 34 34 h ch sub 3 propargyl 40 31 br27 34 34 h 2 benzo hbr 40 40 furanyl28 3 3h h p clph 34 25 2929 34 34 c sub 2 h sub 5 ph 34 50 7630 34 34 h ph 34 40 2531 34 34 ch sub 3 ph 34 40 4832 34 34 h p no sub 2 ph 34 25 2033 34 34 ch sub 3 p clph 34 10 22__________________________________________________________________________ all compounds show a positive effect which may be increased by the use of larger dosages following the procedure set forth in example 4 hydrated compounds according to the following formula were evaluated for antiinflammatory effect with the results shown in table ii str9 table ii______________________________________com dose reductionpound n y r salt mg kg ______________________________________34 2 ph h hbr 100 7035 2 ph ch sub 3 34 150 6836 2 p clph h 34 25 5737 3 ph h 34.